Chargement des cours...
Prévisions
L'objectif de cours moyen des analystes est de 16,07 € (+14,38 %). La médiane est de 16,07 € (+14,38 %).
| Acheter |
14 |
| Conserver |
8 |
| Vendre |
0 |
Actualités Accéder au fil d'actualités
Surgery Partners sells hospital stakes to Intermountain Health; shares rise
Surgery Partners has filed binding contractual documents to sell its stakes in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health. The two facilities are valued at about $1.15 billion, with Surgery Partners receiving roughly $795 million. The company simultaneously confirmed its 2026 guidance (revenue $3.35–3.45 billion; adjusted EBITDA at least $530 million, each excluding the transaction) and emphasized that the proceeds will be used to focus on outpatient surgery centers. The announcement pushed the stock markedly higher intraday; Q2 results are expected on August 10. » Plus sur de.investing.com
Surgery Partners sells two hospitals for $1.15 billion
Surgery Partners agreed to sell Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for about $1.15 billion, after which the stock rose roughly 5.8%. The company expects to receive approximately $795 million in consideration for its ownership interests and a substantial cash inflow at closing, subject to customary purchase price adjustments. The deal still requires various approvals, including physician consents and expiration of Hart‑Scott‑Rodino waiting periods; the partnership with Intermountain Health will remain in place and the physician ownership stake at Mountain View Hospital will be unchanged. Surgery Partners calls the transaction the largest step in its portfolio-optimization strategy, affirms its prior 2026 guidance (revenue $3.35–3.45 billion, adjusted EBITDA at least $530 million) and says it will disclose further details on the financial impact after closing. » Plus sur de.investing.com
Surgery Partners stock falls to 52-week low at $11.53
Surgery Partners closed at $11.53, a 52-week low, after a 45.77% decline over the past six months and a 51.11% drop over 12 months. InvestingPro classifies the stock as volatile (beta 1.94) but considers it undervalued at the current level, citing price targets between $14 and $25. UBS affirmed a buy rating with a $21 target, while RBC cut its target to $20 but kept an outperform rating. Activist Ortelius Advisors is calling for a leadership change; investors are watching the company’s response amid weaker 2026 forecasts and unresolved M&A expectations. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | juin 2026 | YoY |
|---|---|---|
| Chiffre d'affaires | 743,81 M | 6,11 % |
| Bénéfice brut | 166,66 M | 0,42 % |
| Bénéfice net | -13,14 M | 519,65 % |
| EBITDA | 123,9 M | 3,93 % |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 1,87 Md € |
Nombre d'actions | 130,92 M |
Plus haut/bas sur 52 semaines | 20,92 € - 10,19 € |
| Dividendes | Non |
Bêta | 1,91 |
Ratio P/E | -23,17 |
Ratio PEG | -0,59 |
Ratio P/B | 1,23 |
Ratio P/S | 0,62 |
Profil de l'entreprise
Surgery Partners, Inc., par l'intermédiaire de ses filiales, possède et exploite un réseau d'établissements chirurgicaux et de services annexes aux États-Unis. La société opère à travers deux segments, les Services d'établissements chirurgicaux et les Services annexes. Ses établissements chirurgicaux comprennent des centres de chirurgie ambulatoire et des hôpitaux chirurgicaux qui proposent des interventions chirurgicales non urgentes dans diverses spécialités, notamment la gastro-entérologie, la chirurgie générale, l'ophtalmologie, l'orthopédie et la prise en charge de la douleur. Les hôpitaux chirurgicaux de la société proposent également des services annexes, tels que l'imagerie diagnostique, la pharmacie, le laboratoire, l'obstétrique, l'oncologie, la kinésithérapie et les soins de plaies ; et des services annexes, qui consistent en cabinets médicaux multidisciplinaires, centres de soins d'urgence et services d'anesthésie. Au 31 décembre 2021, elle possédait ou exploitait un portefeuille de 126 établissements chirurgicaux, dont 108 centres de chirurgie ambulatoire et 18 hôpitaux chirurgicaux, répartis dans 31 États. Surgery Partners, Inc. a été fondée en 2004 et a son siège social à Brentwood, dans le Tennessee.
| Nom | SURGERY PARTNERS DL -,01 |
| PDG | J. Eric Evans |
| Siège social | Brentwood,
tn États-Unis |
| Site web | |
| Secteur | Santé |
| Industrie | Prestataires et services de santé |
| Introduction en bourse | 30/09/2015 |
| Employés | 16 000 |
Symboles boursiers
| Bourse | Symbole |
|---|---|
NASDAQ | SGRY |
Frankfurt | 1SP.F |
Düsseldorf | 1SP.DU |
München | 1SP.MU |
